Literature DB >> 8307845

Nicotine is responsible for airway irritation evoked by cigarette smoke inhalation in men.

L Y Lee1, D C Gerhardstein, A L Wang, N K Burki.   

Abstract

To determine whether nicotine is involved in evoking the irritant effects of cigarette smoke in airways, we studied the responses to inhalation of a single puff (30 ml) of three types of smoke (high nicotine, low nicotine, and gas phase) in healthy male nonsmokers. After the upper airways were locally anesthetized, the subjects, breathing through a mouthpiece, were instructed to signal the detection and the intensity of airway irritation with a push-button device. Inhalation of high-nicotine smoke consistently triggered an intense airway irritation in the lower neck and upper chest region; the total number of push-button signals generated in the first 5 s was 6.61 +/- 0.87 (mean +/- SE, n = 12), with a detection latency of 0.93 +/- 0.11 s. By contrast, inhalation of low-nicotine and gas phase smoke either was not detected or caused only very mild irritation (0.89 +/- 0.4 and 0.36 +/- 0.22, respectively). In addition, the intensity of smoke-induced airway irritation was markedly reduced after premedication with aerosolized hexamethonium, a nicotinic receptor antagonist (P < 0.01, n = 8). Furthermore, inhalation of nicotine aerosol also immediately evoked intense airway irritation and coughs (n = 5). Thus we conclude that the airway irritation evoked by inhaling cigarette smoke results from an activation of sensory endings located in the central airways and nicotine is the primary agent responsible for this action.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8307845     DOI: 10.1152/jappl.1993.75.5.1955

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  18 in total

1.  The airway sensory impact of nicotine contributes to the conditioned reinforcing effects of individual puffs from cigarettes.

Authors:  Nasir H Naqvi; Antoine Bechara
Journal:  Pharmacol Biochem Behav       Date:  2005-08       Impact factor: 3.533

2.  Skin conductance responses are elicited by the airway sensory effects of puffs from cigarettes.

Authors:  Nasir H Naqvi; Antoine Bechara
Journal:  Int J Psychophysiol       Date:  2006-01-05       Impact factor: 2.997

Review 3.  Nicotine and nonnicotine factors in cigarette addiction.

Authors:  Jed E Rose
Journal:  Psychopharmacology (Berl)       Date:  2005-12-16       Impact factor: 4.530

Review 4.  Effect of smoking on cough reflex sensitivity: basic and preclinical studies.

Authors:  Lu-Yuan Lee; Qihai Gu; You-Shuei Lin
Journal:  Lung       Date:  2009-10-21       Impact factor: 2.584

5.  Inhalation of electronic cigarette aerosol induces reflex bronchoconstriction by activation of vagal bronchopulmonary C-fibers.

Authors:  M Khosravi; R L Lin; L-Y Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-05-31       Impact factor: 5.464

6.  Nicotine content and abstinence state have different effects on subjective ratings of positive versus negative reinforcement from smoking.

Authors:  Kimberly P Lindsey; Bethany K Bracken; Robert R Maclean; Elizabeth T Ryan; Scott E Lukas; Blaise Deb Frederick
Journal:  Pharmacol Biochem Behav       Date:  2012-12-03       Impact factor: 3.533

Review 7.  Targeting peripheral afferent nerve terminals for cough and dyspnea.

Authors:  Yukiko Muroi; Bradley J Undem
Journal:  Curr Opin Pharmacol       Date:  2011-06-24       Impact factor: 5.547

8.  Expression of neuronal nicotinic acetylcholine receptors in rat vagal pulmonary sensory neurons.

Authors:  Qihai Gu; Dan Ni; Lu-Yuan Lee
Journal:  Respir Physiol Neurobiol       Date:  2007-12-08       Impact factor: 1.931

Review 9.  The hidden island of addiction: the insula.

Authors:  Nasir H Naqvi; Antoine Bechara
Journal:  Trends Neurosci       Date:  2008-11-03       Impact factor: 13.837

Review 10.  Respiratory sensations evoked by activation of bronchopulmonary C-fibers.

Authors:  Lu-Yuan Lee
Journal:  Respir Physiol Neurobiol       Date:  2008-05-18       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.